As we conclude the conference, we would like to express our deepest gratitude to all the contributors and participants who made the Second Combined #SSBMT and #SSH24 Annual Conference a great success. Thank you for your valuable support and expertise.
#SaudiHematology 24
Join us for our upcoming #SSBMT webinar, "MDS in Focus: Navigating the Evolving Landscape and Optimizing Early Disease Management."
📅 June 20, 2026 🕗 8:00 PM KSA Time
Hear from our distinguished panel of experts:
· Dr. Iman Alhazmi (KFAFH, Jeddah)
· Dr. Bader Alahmari (KAMC, Riyadh)
· Dr. Bassim Albeirouti (KFSH&RC, Jeddah)
Don’t miss this comprehensive update in MDS care!
Register here: https://t.co/GHSCYPtnYK
في ختام هذا اللقاء وبرنامجه العلمي الثري ، أشكر وأقدر كل من حضر وشارك ونظم . استفدنا واستمتعنا. نفع الله بكم ووفقنا جميعا لخدمة المرضى والوطن ، ونلقاكم قريبا على خير في تجمع علمي آخر .
Huge thanks to all the dedicated nurses who stayed until the very end of the Annual Saudi Hem/Onc Nurses meeting!
We appreciate the rich agenda and the incredible participation of the @EBMTNurses Group. Looking forward to next year!
#SaudiHematology#EBMT#SaudiHemOncNursing
A huge congratulations and thank you to the organizing and scientific committees of the 15th Annual #SSBMT#EBMT 2026 Highlights! 👏👏
Thank you for building such an exceptional program. Bringing the best of @EBMT highlights to our region resulted in phenomenal attendee turnout and incredible engagement!
#SaudiHematology 26
As therapies evolve, so must our education!
Ms. Silvia Gnecci just presented a vital topic: "The impact of novel therapies on clinical nursing education." Staying ahead of these innovations ensures our nursing workforce remains world-class.
#SSBMT#EBMT#SaudiHemOncNursing
#SaudiHematology
Shifting focus to clinical advancements!
Dr. Izaskun Zeberio is currently on stage presenting on malignant hematology, diving deep into the most recent updates and breakthroughs in Hodgkin Lymphoma (HL). Vital insights for our specialized nursing community!
#SSBMT#EBMT #SaudiHemOncNursing #SaudiHematology
Bringing global excellence home! 🇸🇦✨
Thank you, Ms. Hilda Mekelenkamp, for sharing the "Best of the Best" abstracts from the EBMT Nurses Group meeting. Incredible data and key takeaways to help our hematology and oncology nurses elevate patient care.
#SSBMT#EBMT #SaudiHemOncNursing #SaudiHematology
"Collaboration drives excellence in care."
Inspiring welcome remarks from Ms. Hilda Mekelenkamp today! She shared insights on the EBMT Nurses Group’s mission and our shared commitment with SSBMT to elevate nursing education and professional growth across the Kingdom.
#SSBMT #EBMT #SaudiHemOncNursing
#SaudiHematology
Now Live! The 13th Annual Saudi Hematology/Oncology Nurses Group Meeting has officially started.
Proud to support the incredible nurses advancing patient care, stem cell transplantation, and oncology treatments across the Kingdom. Stay tuned for updates! 🇸🇦
#SSBMT#EBMT
#EBMTnurses
#SaudiHemOncNursing
#SaudiHematology
An absolute highlight of Day 2 at #SSBMT#EBMT 2026! Dr. Selim Corbacioglu is taking the stage to discuss the rapidly evolving landscape of hemoglobinopathies.
From curative allogeneic HSCT to groundbreaking advancements in gene therapy and gene editing, the future of managing Thalassemia and Sickle Cell Disease is here.
#SaudiHematology 26
Dr. Eleni Gavriilaki presenting right now at #SSBMT#EBMT 2026!
She is sharing essential updates on navigating the complexities of TA-TMA diagnostic consensus criteria, emphasizing the push toward individualized patient screening and severity scoring.
#SaudiHematology 26
Currently at Day 2 of #SSBMT#EBMT 2026: Dr. Hind Salama's presentation on HLH and IEC-HS showcases innovative efforts in treating adult histiocytic disorders and managing immune effector cell complications.
#SaudiHematology 26
Fascinating presentation by Dr. Ashraf Warsi on navigating the complexities of Paroxysmal Nocturnal Hemoglobinuria (PNH) at the 15th Annual #SSBMT#EBMT26 Highlights!
From classic hemolytic PNH to subclinical clones in bone marrow failure, precision monitoring is changing patient outcomes.
#SaudiHematology 26
How are we optimizing outcomes in Myelofibrosis?
Dr. Juan Carlos Boluda delivered a brilliant session at #SSBMT#EBMT26 on integrating novel agents with allogeneic HCT. By strategically combining targeted therapies like JAK inhibitors with transplant protocols, we are paving the way for safer, more effective curative pathways. #SaudiHematology 26
How are we stratifying Severe Aplastic Anemia (SAA) patients today?
Prof. Antonio Risitano shared crucial guidelines at the 15th Annual #SSBMT#EBMT 26 Highlights. The core message: Age, donor speed, and clonal dynamics dictate the choice between upfront allo-HSCT and Triple IST. #SaudiHematology 26
We are LIVE for Day 2 of the 15th Annual #SSBMT#EBMT 2026 Highlights!
The insights have been incredible so far, and we’re just getting started. Standing by for the Annual Saudi Hem/Onc nursing group sessions coming up later today—make sure your notifications are on! #SaudiHematology 26 #SaudiHemOncNursing 26
https://t.co/CLzkl0Yo7W
How do we turn Myelofibrosis evidence into action? Dr. Ayman Almozaini is presenting local experience highlighting the real data at #SSBMT#EBMT 2026.
#SaudiHematology 26
Moving the needle in MPN care! Dr. Rawan Almohammady is on stage at #SSBMT#EBMT 2026 discussing the latest updates in Myelofibrosis. From JAK inhibitor combinations to disease-modifying therapies, the future of treatment is looking brighter for our patients.
#SaudiHematology 26
Are Menin inhibitors the next frontier in AML? Dr. Bader Alahmari is breaking down the latest clinical data and therapeutic potential at the #SSBMT#EBMT 2026 Annual Conf.
#SaudiHematology 26